Skip to content

BIO: How the PASTEUR Act would support antibiotic R&D The PASTEUR Act, legislation designed to make research and development of new antibiotics economically viable, was reintroduced in Congress last week with bipartisan support. Here’s what it would do and why it matters. Antimicrobial resistance is a big problem. AMR occurs when bacteria, viruses, fungi and…

Read More
2021 Life Sciences Workforce Trends Report cover

2021 CSBI-TEConomy Workforce Trends Report released The Coalition of State Bioscience Institutes released the 2021 Life Sciences Workforce Trends Report (PDF) in June 2021 at the BIO Digital Convention. The report provides a national snapshot of the current and anticipated talent needs of the nation’s dynamic life science industry. The report leverages intelligence drawn from…

Read More

BMF covers improving manufacturing with automation, digitization Salil Desai, Ph.D., says “digital twinning” is the future of biomanufacturing. Presenters from Novozymes, Pfizer and North Carolina A&T State University discussed optimizing production processes using automation and digitization during the June 8 Biomanufacturers Forum held online by NCBIO.  The forum featured presentations by the following experts:  Mike…

Read More

Vaccine patent waiver breaks faith with American companies, stifles innovation NCBIO is extremely disappointed that the Biden administration has chosen to support waiving critical intellectual property protections for U.S. COVID-19 vaccines. This decision, known as a TRIPS waiver, breaks faith with American innovators, punishes the ingenuity of our life sciences industry and will delay the…

Read More

BIO President and CEO Dr. Michelle McMurry-Heath sent a letter April 19 to U.S. Trade Representative Ambassador Katherine Tai to explain why the WTO’s proposed “TRIPS waiver” would have global health and economic consequences as the pandemic rages on.

Read More

Like last year, this year’s Venture Connect held March 23-25 produced by the Council for Entrepreneurial Development took place entirely online but with many new features.  NCBIO is a sponsor of Venture Connect, which connects life science and technology companies in the Southeast with investors, sponsors and fellow entrepreneurs to network, discuss innovative technologies and…

Read More
Congressional Record

REMEMBERING SAM TAYLOR Mr. Tillis. Madam President, I rise today with my colleague, the senior Senator from North Carolina, to honor the life and work of Sam Taylor, the president of North Carolina Biosciences Organization. Sam was a giant in our State and a leading voice for our vital and innovative life sciences and biopharmaceutical…

Read More

NCBIO manufacturing companies discussed their workforce needs with North Carolina state legislators during the quarterly meeting of the NCBIO Biomanufacturers Forum held online Tuesday, March 2. Representatives of Biogen, FUJIFILM DioSynth, Grifols, Merck, Novartis, Novozymes and Pfizer were among those who spoke to leaders of the NC General Assembly’s Life Sciences Caucus. Caucus co-chairs Sen.…

Read More